Jane Street
TARS icon

Jane Street’s Tarsus Pharmaceuticals TARS Stock Holding History

Jane Street’s Portfolio TARS Stock Details TARS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-20,486
Closed -$1.43M – 12948
2025
Q4 		$1.68M Sell
20,486
-40,134
-66% -$3M ﹤0.01% 5153
2025
Q3 		$3.6M Buy
+60,620
New +$2.98M ﹤0.01% 3924
2025
Q2 		– Sell
-10,456
Closed -$537K – 10857
2025
Q1 		$537K Sell
10,456
-46,800
-82% -$2.31M ﹤0.01% 6728
2024
Q4 		$3.17M Buy
57,256
+29,675
+108% +$1.35M ﹤0.01% 3354
2024
Q3 		$907K Sell
27,581
-51,266
-65% -$1.44M ﹤0.01% 6082
2024
Q2 		$2.14M Buy
78,847
+40,572
+106% +$1.36M ﹤0.01% 4355
2024
Q1 		$1.39M Buy
38,275
+19,119
+100% +$562K ﹤0.01% 4792
2023
Q4 		$388K Sell
19,156
-19,657
-51% -$328K ﹤0.01% 7211
2023
Q3 		$690K Buy
+38,813
New +$687K ﹤0.01% 5756

Other funds holding TARS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Jane Street's TARS Position: Q1 2026 in Review

Jane Street sold out of Tarsus Pharmaceuticals (TARS) in Q1 2026, closing a stake of 20,486 shares — an estimated $1.43M sold.

Jane Street first reported a position in TARS in Q3 2023 and held it in 9 quarters. The position peaked at $3.6M in Q3 2025. 253 funds tracked by Wall St. Rank hold TARS as of Q1 2026.

  • Jane Street reported no remaining Tarsus Pharmaceuticals position as of Q1 2026 after selling out during the quarter.
  • Jane Street sold 20,486 Tarsus Pharmaceuticals shares in Q1 2026, an estimated $1.43M.
  • Jane Street first reported a position in Tarsus Pharmaceuticals in Q3 2023 and held it in 9 quarters.
  • Jane Street's Tarsus Pharmaceuticals position peaked at $3.6M in Q3 2025.
  • 253 funds tracked by Wall St. Rank held Tarsus Pharmaceuticals as of Q1 2026.

Based on Jane Street's 13F filing for Q1 2026, filed 12 May 2026.